CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: limonoid
Accession: CHEBI:39434
browse the term
Definition: Any triterpenoid that is highly oxygenated and has a prototypical structure either containing or derived from a precursor with a 4,4,8-trimethyl-17-furanylsteroid skeleton. The term 'limonoid' comes from limonin, the first tetranortriterpenoid obtained from citrus bitter principles.
Synonyms: related_synonym: limonoids
xref: PMID:16462017; Wikipedia:Limonoid
G
Casp3
caspase 3
increases activity
ISO
28-deoxonimbolide results in increased activity of CASP3 protein
CTD
PMID:21381696
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
28-deoxonimbolide results in increased activity of CASP8 protein
CTD
PMID:21381696
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
28-deoxonimbolide results in increased activity of CASP9 protein
CTD
PMID:21381696
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Acp5
acid phosphatase 5, tartrate resistant
decreases expression multiple interactions
ISO
azadirachtin results in decreased expression of ACP5 mRNA azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA]
CTD
PMID:31225646
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
azadirachtin results in increased expression of APAF1 protein
CTD
PMID:20429769
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
azadirachtin results in increased expression of BAD mRNA
CTD
PMID:20429769
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
azadirachtin results in increased expression of BAX mRNA
CTD
PMID:20429769
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
azadirachtin results in decreased expression of BCL2 mRNA; azadirachtin results in decreased expression of BCL2 protein
CTD
PMID:20429769
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
azadirachtin results in decreased expression of BCL2L1 mRNA
CTD
PMID:20429769
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bglap
bone gamma-carboxyglutamate protein
multiple interactions
ISO
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of BGLAP protein]
CTD
PMID:31225646
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bid
BH3 interacting domain death agonist
increases expression
ISO
azadirachtin results in increased expression of BID mRNA
CTD
PMID:20429769
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
azadirachtin results in decreased expression of BIRC5 protein
CTD
PMID:20429769
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
azadirachtin results in increased expression of BMP2 mRNA; azadirachtin results in increased expression of BMP2 protein
CTD
PMID:31225646
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Casp3
caspase 3
increases expression
ISO
azadirachtin results in increased expression of CASP3 mRNA; azadirachtin results in increased expression of CASP3 protein
CTD
PMID:20429769
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
azadirachtin results in increased expression of CASP6 protein
CTD
PMID:20429769
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
increases expression
ISO
azadirachtin results in increased expression of CASP8 protein
CTD
PMID:20429769
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression
ISO
azadirachtin results in increased expression of CASP9 mRNA; azadirachtin results in increased expression of CASP9 protein
CTD
PMID:20429769
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccnd1
cyclin D1
decreases expression
ISO
azadirachtin results in decreased expression of CCND1 mRNA
CTD
PMID:20429769
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
azadirachtin results in increased expression of CDKN1A mRNA; azadirachtin results in increased expression of CDKN1A protein
CTD
PMID:20429769
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cycs
cytochrome c, somatic
increases expression affects localization
ISO
azadirachtin results in increased expression of CYCS mRNA azadirachtin affects the localization of CYCS protein
CTD
PMID:20429769
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Esr1
estrogen receptor 1
increases expression multiple interactions affects binding
ISO
azadirachtin results in increased expression of ESR1 mRNA; azadirachtin results in increased expression of ESR1 protein 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 mRNA]; 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 protein]; azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR1 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein] azadirachtin binds to ESR1 protein
CTD
PMID:31225646
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions affects binding increases expression
ISO
azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR2 mRNA] azadirachtin binds to ESR2 protein azadirachtin results in increased expression of ESR2 mRNA; azadirachtin results in increased expression of ESR2 protein
CTD
PMID:31225646
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases expression
ISO
azadirachtin results in decreased expression of IKBKB protein
CTD
PMID:20429769
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
azadirachtin results in increased phosphorylation of MAPK1 protein
CTD
PMID:31225646
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
azadirachtin results in increased phosphorylation of MAPK3 protein
CTD
PMID:31225646
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
azadirachtin results in decreased expression of NFKB1 protein
CTD
PMID:20429769
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
decreases expression
ISO
azadirachtin results in decreased expression of NFKBIA protein modified form
CTD
PMID:20429769
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
azadirachtin results in decreased expression of PCNA mRNA; azadirachtin results in decreased expression of PCNA protein
CTD
PMID:20429769
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
ISO
azadirachtin results in decreased expression of RELA protein
CTD
PMID:20429769
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Runx2
RUNX family transcription factor 2
increases expression multiple interactions
ISO
azadirachtin results in increased expression of RUNX2 mRNA; azadirachtin results in increased expression of RUNX2 protein ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein]
CTD
PMID:31225646
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Smad1
SMAD family member 1
increases expression
ISO
azadirachtin results in increased expression of SMAD1 protein modified form
CTD
PMID:31225646
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Tnf
tumor necrosis factor
decreases expression
ISO
azadirachtin results in decreased expression of TNF mRNA
CTD
PMID:31225646
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11a
TNF receptor superfamily member 11A
multiple interactions decreases expression
ISO
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of TNFRSF11A mRNA] azadirachtin results in decreased expression of TNFRSF11A mRNA
CTD
PMID:31225646
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
G
Tp53
tumor protein p53
increases expression
ISO
azadirachtin results in increased expression of TP53 mRNA; azadirachtin results in increased expression of TP53 protein
CTD
PMID:20429769
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Casp3
caspase 3
increases activity
ISO
azadiradione results in increased activity of CASP3 protein
CTD
PMID:21381696
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
azadiradione results in increased activity of CASP8 protein
CTD
PMID:21381696
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
azadiradione results in increased activity of CASP9 protein
CTD
PMID:21381696
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
azadiradione results in increased expression of HSPA1A mRNA
CTD
PMID:30309986
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
cedrelone analog results in decreased phosphorylation of AKT1 protein
CTD
PMID:31857088
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
cedrelone analog results in increased expression of BAX protein
CTD
PMID:31857088
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
cedrelone analog results in decreased expression of BCL2 protein
CTD
PMID:31857088
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
affects cleavage
ISO
cedrelone analog affects the cleavage of CASP3 protein
CTD
PMID:31857088
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
cedrelone analog results in decreased expression of EGFR protein
CTD
PMID:31857088
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Itgb1
integrin subunit beta 1
decreases expression
ISO
cedrelone analog results in decreased expression of ITGB1 protein
CTD
PMID:31857088
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Mmp9
matrix metallopeptidase 9
decreases activity
ISO
cedrelone analog results in decreased activity of MMP9 protein
CTD
PMID:31857088
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
cedrelone analog results in decreased expression of NFKB1 protein
CTD
PMID:31857088
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
gedunin results in increased expression of AHSA1 mRNA
CTD
PMID:17010675
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
gedunin results in increased expression of AKR1C1 mRNA
CTD
PMID:17010675
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
gedunin results in increased expression of AKR1C2 mRNA
CTD
PMID:17010675
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Ar
androgen receptor
decreases expression
ISO
gedunin results in decreased expression of AR protein
CTD
PMID:17010675
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arid5b
AT-rich interaction domain 5B
decreases expression
ISO
gedunin results in decreased expression of ARID5B mRNA
CTD
PMID:17010675
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Atf3
activating transcription factor 3
increases expression
ISO
gedunin results in increased expression of ATF3 mRNA
CTD
PMID:17010675
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Bag3
BAG cochaperone 3
increases expression
ISO
gedunin results in increased expression of BAG3 mRNA
CTD
PMID:17010675
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
gedunin results in decreased expression of BIRC5 mRNA
CTD
PMID:17010675
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
gedunin results in decreased expression of BTG1 mRNA
CTD
PMID:17010675
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Cacybp
calcyclin binding protein
increases expression
ISO
gedunin results in increased expression of CACYBP mRNA
CTD
PMID:17010675
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
G
Casp3
caspase 3
increases activity
ISO
gedunin results in increased activity of CASP3 protein
CTD
PMID:21381696
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
gedunin results in increased activity of CASP8 protein
CTD
PMID:21381696
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
gedunin results in increased activity of CASP9 protein
CTD
PMID:21381696
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cbr3
carbonyl reductase 3
increases expression
ISO
gedunin results in increased expression of CBR3 mRNA
CTD
PMID:17010675
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
G
Cdc7
cell division cycle 7
decreases expression
ISO
gedunin results in decreased expression of CDC7 mRNA
CTD
PMID:17010675
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
gedunin results in decreased expression of CDK2 mRNA
CTD
PMID:17010675
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
gedunin results in increased expression of CHORDC1 mRNA
CTD
PMID:17010675
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
ISO
gedunin results in decreased expression of CITED2 mRNA
CTD
PMID:17010675
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
gedunin results in decreased expression of CYP1A1 mRNA
CTD
PMID:17010675
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
gedunin results in increased expression of DDIT3 mRNA
CTD
PMID:17010675
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
gedunin results in increased expression of DDIT4 mRNA
CTD
PMID:17010675
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
increases expression
ISO
gedunin results in increased expression of DNAJA1 mRNA
CTD
PMID:17010675
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
gedunin results in increased expression of DNAJB4 mRNA
CTD
PMID:17010675
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Efnb2
ephrin B2
decreases expression
ISO
gedunin results in decreased expression of EFNB2 mRNA
CTD
PMID:17010675
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
gedunin results in decreased expression of EGFR protein
CTD
PMID:17010675
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ficd
FIC domain protein adenylyltransferase
increases expression
ISO
gedunin results in increased expression of FICD mRNA
CTD
PMID:17010675
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
G
Flt3
Fms related receptor tyrosine kinase 3
decreases expression
ISO
gedunin results in decreased expression of FLT3 protein
CTD
PMID:17010675
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
gedunin results in decreased expression of GATD3 mRNA
CTD
PMID:17010675
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
gedunin results in increased expression of GCLM mRNA
CTD
PMID:17010675
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
gedunin results in increased expression of GDF15 mRNA
CTD
PMID:17010675
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gtpbp2
GTP binding protein 2
increases expression
ISO
gedunin results in increased expression of GTPBP2 mRNA
CTD
PMID:17010675
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
G
Hilpda
hypoxia inducible lipid droplet-associated
decreases expression
ISO
gedunin results in decreased expression of HILPDA mRNA
CTD
PMID:17010675
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
gedunin results in increased expression of HMGCS1 mRNA
CTD
PMID:17010675
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression
ISO
gedunin results in increased expression of HMOX1 mRNA
CTD
PMID:17010675
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases activity
ISO
gedunin results in decreased activity of HSP90AA1 protein
CTD
PMID:17010675
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa13
heat shock protein family A (Hsp70) member 13
increases expression
ISO
gedunin results in increased expression of HSPA13 mRNA
CTD
PMID:17010675
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
gedunin results in increased expression of HSPA1A mRNA
CTD
PMID:17010675
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
gedunin results in increased expression of HSPA1B mRNA
CTD
PMID:17010675
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
gedunin results in increased expression of HSPA5 mRNA
CTD
PMID:17010675
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
gedunin results in increased expression of HSPH1 mRNA
CTD
PMID:17010675
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Il1rn
interleukin 1 receptor antagonist
decreases expression
ISO
gedunin results in decreased expression of IL1RN mRNA
CTD
PMID:17010675
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Insig1
insulin induced gene 1
increases expression
ISO
gedunin results in increased expression of INSIG1 mRNA
CTD
PMID:17010675
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Jag1
jagged canonical Notch ligand 1
decreases expression
ISO
gedunin results in decreased expression of JAG1 mRNA
CTD
PMID:17010675
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
decreases expression
ISO
gedunin results in decreased expression of KCNN2 mRNA
CTD
PMID:17010675
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
gedunin results in increased expression of LDLR mRNA
CTD
PMID:17010675
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lpin1
lipin 1
increases expression
ISO
gedunin results in increased expression of LPIN1 mRNA
CTD
PMID:17010675
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Ltn1
listerin E3 ubiquitin protein ligase 1
decreases expression
ISO
gedunin results in decreased expression of LTN1 mRNA
CTD
PMID:17010675
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
G
Mafb
MAF bZIP transcription factor B
decreases expression
ISO
gedunin results in decreased expression of MAFB mRNA
CTD
PMID:17010675
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Mdh2
malate dehydrogenase 2
decreases expression
ISO
gedunin results in decreased expression of MDH2 mRNA
CTD
PMID:17010675
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Me1
malic enzyme 1
increases expression
ISO
gedunin results in increased expression of ME1 mRNA
CTD
PMID:17010675
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mnt
MAX network transcriptional repressor
increases expression
ISO
gedunin results in increased expression of MNT mRNA
CTD
PMID:17010675
NCBI chr10:59,699,208...59,714,848
Ensembl chr10:59,699,585...59,714,835
G
Mrpl18
mitochondrial ribosomal protein L18
increases expression
ISO
gedunin results in increased expression of MRPL18 mRNA
CTD
PMID:17010675
NCBI chr 1:47,837,169...47,841,987
Ensembl chr 1:47,836,561...47,841,987
G
Msh6
mutS homolog 6
decreases expression
ISO
gedunin results in decreased expression of MSH6 mRNA
CTD
PMID:17010675
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Msmo1
methylsterol monooxygenase 1
increases expression
ISO
gedunin results in increased expression of MSMO1 mRNA
CTD
PMID:17010675
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Mycbp2
MYC binding protein 2
decreases expression
ISO
gedunin results in decreased expression of MYCBP2 mRNA
CTD
PMID:17010675
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
G
Mynn
myoneurin
decreases expression
ISO
gedunin results in decreased expression of MYNN mRNA
CTD
PMID:17010675
NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397
G
Nbn
nibrin
decreases expression
ISO
gedunin results in decreased expression of NBN mRNA
CTD
PMID:17010675
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Nkx3-1
NK3 homeobox 1
decreases expression
ISO
gedunin results in decreased expression of NKX3-1 mRNA
CTD
PMID:17010675
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
gedunin results in decreased expression of NREP mRNA
CTD
PMID:17010675
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Oprk1
opioid receptor, kappa 1
decreases expression
ISO
gedunin results in decreased expression of OPRK1 mRNA
CTD
PMID:17010675
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
G
Oser1
oxidative stress responsive serine-rich 1
increases expression
ISO
gedunin results in increased expression of OSER1 mRNA
CTD
PMID:17010675
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
G
Pde9a
phosphodiesterase 9A
decreases expression
ISO
gedunin results in decreased expression of PDE9A mRNA
CTD
PMID:17010675
NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
decreases expression
ISO
gedunin results in decreased expression of PIK3CD mRNA
CTD
PMID:17010675
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
ISO
gedunin results in decreased expression of PIK3R1 mRNA
CTD
PMID:17010675
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
[gedunin co-treated with Glucose] binds to PPARA protein; gedunin inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]]
CTD
PMID:18812576
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppif
peptidylprolyl isomerase F
decreases expression
ISO
gedunin results in decreased expression of PPIF mRNA
CTD
PMID:17010675
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
G
Pura
purine rich element binding protein A
decreases expression
ISO
gedunin results in decreased expression of PURA mRNA
CTD
PMID:17010675
NCBI chr18:27,885,071...27,905,509
Ensembl chr18:27,884,556...27,905,513
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
gedunin results in decreased expression of RRM2 mRNA
CTD
PMID:17010675
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Serp1
stress-associated endoplasmic reticulum protein 1
increases expression
ISO
gedunin results in increased expression of SERP1 mRNA
CTD
PMID:17010675
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
G
Sesn1
sestrin 1
decreases expression
ISO
gedunin results in decreased expression of SESN1 mRNA
CTD
PMID:17010675
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
gedunin results in increased expression of SLC3A2 mRNA
CTD
PMID:17010675
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
gedunin results in increased expression of SLC7A11 mRNA
CTD
PMID:17010675
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Sltm
SAFB-like, transcription modulator
decreases expression
ISO
gedunin results in decreased expression of SLTM mRNA
CTD
PMID:17010675
NCBI chr 8:71,215,995...71,261,821
Ensembl chr 8:71,216,612...71,261,825
G
Sox4
SRY-box transcription factor 4
decreases expression
ISO
gedunin results in decreased expression of SOX4 mRNA
CTD
PMID:17010675
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Stip1
stress-induced phosphoprotein 1
increases expression
ISO
gedunin results in increased expression of STIP1 mRNA
CTD
PMID:17010675
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Taok3
TAO kinase 3
decreases expression
ISO
gedunin results in decreased expression of TAOK3 mRNA
CTD
PMID:17010675
NCBI chr12:39,312,354...39,473,656
Ensembl chr12:39,314,027...39,461,244
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
gedunin results in decreased expression of TXNIP mRNA
CTD
PMID:17010675
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
gedunin results in increased expression of TXNRD1 mRNA
CTD
PMID:17010675
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ube2b
ubiquitin-conjugating enzyme E2B
increases expression
ISO
gedunin results in increased expression of UBE2B mRNA
CTD
PMID:17010675
NCBI chr10:36,248,434...36,263,379
Ensembl chr10:36,248,438...36,264,665
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
gedunin results in increased expression of UGDH mRNA
CTD
PMID:17010675
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Wdr77
WD repeat domain 77
decreases expression
ISO
gedunin results in decreased expression of WDR77 mRNA
CTD
PMID:17010675
NCBI chr 2:193,435,465...193,445,534
Ensembl chr 2:193,435,468...193,445,520
G
Zbtb43
zinc finger and BTB domain containing 43
decreases expression
ISO
gedunin results in decreased expression of ZBTB43 mRNA
CTD
PMID:17010675
NCBI chr 3:16,744,535...16,763,854
Ensembl chr 3:16,744,535...16,763,909
G
Zc3h12a
zinc finger CCCH type containing 12A
decreases expression
ISO
gedunin results in decreased expression of ZC3H12A mRNA
CTD
PMID:17010675
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression multiple interactions
ISO
limonin results in decreased expression of ALDH1A1 mRNA limonin results in decreased expression of and results in decreased activity of ALDH1A1 protein
CTD
PMID:30738134
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of BCL2 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]]; limonin inhibits the reaction [Arginine results in increased expression of BCL2 mRNA]; limonin inhibits the reaction [Arginine results in increased expression of BCL2 protein]; limonin inhibits the reaction [Ceruletide results in increased expression of BCL2 mRNA]; limonin inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]
CTD
PMID:34423886
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity
ISO
limonin results in increased activity of CASP3 protein
CTD
PMID:31702096
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
ISO
limonin results in increased activity of CASP9 protein
CTD
PMID:31702096
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
limonin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]
CTD
PMID:31702096
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased secretion of CCL2 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased secretion of CCL2 protein]]; limonin inhibits the reaction [Arginine results in increased secretion of CCL2 protein]; limonin inhibits the reaction [Ceruletide results in increased secretion of CCL2 protein]
CTD
PMID:34423886
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
limonin results in decreased expression of CCN2 mRNA
CTD
PMID:30738134
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnd1
cyclin D1
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of CCND1 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of CCND1 protein]]; limonin inhibits the reaction [Arginine results in increased expression of CCND1 mRNA]; limonin inhibits the reaction [Arginine results in increased expression of CCND1 protein]; limonin inhibits the reaction [Ceruletide results in increased expression of CCND1 mRNA]; limonin inhibits the reaction [Ceruletide results in increased expression of CCND1 protein]
CTD
PMID:34423886
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdh1
cadherin 1
increases expression
ISO
limonin results in increased expression of CDH1 mRNA; limonin results in increased expression of CDH1 protein
CTD
PMID:30738134
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
limonin results in decreased activity of CYP3A4 protein
CTD
PMID:22001672
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ephx2
epoxide hydrolase 2
multiple interactions
ISO
limonin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog]
CTD
PMID:2043152
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
limonin inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]
CTD
PMID:31702096
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of HMOX1 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of HMOX1 protein]]; limonin inhibits the reaction [Arginine results in increased expression of HMOX1 protein]; limonin inhibits the reaction [Ceruletide results in increased expression of HMOX1 protein]
CTD
PMID:34423886
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il1b
interleukin 1 beta
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased secretion of IL1B protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased secretion of IL1B protein]]; limonin inhibits the reaction [Arginine results in increased secretion of IL1B protein]; limonin inhibits the reaction [Benzo(a)pyrene results in increased activity of IL1B protein]; limonin inhibits the reaction [Ceruletide results in increased secretion of IL1B protein]
CTD
PMID:31702096 PMID:34423886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased secretion of IL6 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased secretion of IL6 protein]]; limonin inhibits the reaction [Arginine results in increased secretion of IL6 protein]; limonin inhibits the reaction [Ceruletide results in increased secretion of IL6 protein]
CTD
PMID:34423886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jak2
Janus kinase 2
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of JAK2 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of JAK2 protein]]; limonin inhibits the reaction [Arginine results in increased expression of JAK2 protein]; limonin inhibits the reaction [Ceruletide results in increased expression of JAK2 protein]
CTD
PMID:34423886
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Nanog
Nanog homeobox
decreases expression
ISO
limonin results in decreased expression of NANOG mRNA; limonin results in decreased expression of NANOG protein
CTD
PMID:30738134
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased phosphorylation of STAT3 protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased phosphorylation of STAT3 protein]]; limonin inhibits the reaction [Arginine results in increased phosphorylation of STAT3 protein]; limonin inhibits the reaction [Ceruletide results in increased phosphorylation of STAT3 protein]
CTD
PMID:34423886
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased secretion of TNF protein]]; coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased secretion of TNF protein]]; limonin inhibits the reaction [Arginine results in increased secretion of TNF protein]; limonin inhibits the reaction [Benzo(a)pyrene results in increased activity of TNF protein]; limonin inhibits the reaction [Ceruletide results in increased secretion of TNF protein]
CTD
PMID:31702096 PMID:34423886
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vim
vimentin
decreases expression
ISO
limonin results in decreased expression of VIM mRNA; limonin results in decreased expression of VIM protein
CTD
PMID:30738134
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Yap1
Yes1 associated transcriptional regulator
affects localization
ISO
limonin affects the localization of YAP1 protein
CTD
PMID:30738134
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
G
Ephx2
epoxide hydrolase 2
multiple interactions
ISO
nomilin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog]
CTD
PMID:2043152
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Akt1
AKT serine/threonine kinase 1
decreases expression multiple interactions
ISO
obacunone results in decreased expression of AKT1 protein modified form obacunone results in decreased expression of and results in decreased phosphorylation of AKT1 protein
CTD
PMID:25592883
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Ar
androgen receptor
affects expression
ISO
obacunone affects the expression of AR protein
CTD
PMID:25592883
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
obacunone results in increased expression of BAD protein
CTD
PMID:25592883
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
obacunone results in increased expression of BAX mRNA; obacunone results in increased expression of BAX protein
CTD
PMID:21333732 PMID:25592883
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
obacunone results in decreased expression of BCL2 mRNA; obacunone results in decreased expression of BCL2 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity decreases expression multiple interactions
ISO
obacunone results in increased activity of CASP3 protein obacunone results in decreased expression of CASP3 protein obacunone results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
decreases expression increases cleavage
ISO
obacunone results in decreased expression of CASP8 protein obacunone results in increased cleavage of CASP8 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity increases cleavage
ISO
obacunone results in increased activity of CASP9 protein obacunone results in increased cleavage of CASP9 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
obacunone results in increased expression of CDKN1A protein
CTD
PMID:25592883
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Il6
interleukin 6
decreases expression
ISO
obacunone results in decreased expression of IL6 protein
CTD
PMID:25592883
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression
ISO
obacunone results in decreased expression of KLK3 protein
CTD
PMID:25592883
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
obacunone results in decreased expression of PTGS2 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
ISO
obacunone results in decreased expression of RELA protein
CTD
PMID:21333732
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tp53
tumor protein p53
increases expression
ISO
obacunone results in increased expression of TP53 protein
CTD
PMID:21333732 PMID:25592883
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
toosendanin inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]
CTD
PMID:35101544
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Atf3
activating transcription factor 3
increases expression
ISO
toosendanin results in increased expression of ATF3 protein toosendanin results in increased expression of ATF3 mRNA; toosendanin results in increased expression of ATF3 protein
CTD
PMID:36801351
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression
ISO
toosendanin results in increased expression of ATF4 protein toosendanin results in increased expression of ATF4 mRNA; toosendanin results in increased expression of ATF4 protein
CTD
PMID:36801351
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
toosendanin results in increased expression of BAX protein
CTD
PMID:23111283
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
toosendanin results in decreased expression of BCL2 protein
CTD
PMID:23111283
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
toosendanin analog results in decreased expression of BCL2L1 protein; toosendanin results in decreased expression of BCL2L1 protein
CTD
PMID:34742683
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
increases expression
ISO
toosendanin analog results in increased expression of BECN1 protein; toosendanin results in increased expression of BECN1 protein
CTD
PMID:34742683
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Casp3
caspase 3
increases cleavage increases expression
ISO
toosendanin analog results in increased cleavage of CASP3 protein; toosendanin results in increased cleavage of CASP3 protein toosendanin results in increased expression of CASP3 protein modified form
CTD
PMID:23111283 PMID:34742683
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage
ISO
toosendanin analog results in increased cleavage of CASP9 protein; toosendanin results in increased cleavage of CASP9 protein
CTD
PMID:34742683
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cdc42
cell division cycle 42
decreases expression
ISO
toosendanin results in decreased expression of CDC42 protein
CTD
PMID:23111283
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions affects expression
ISO
toosendanin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein toosendanin affects the expression of EIF2AK3 mRNA
CTD
PMID:36801351
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation affects expression
ISO
toosendanin results in increased phosphorylation of EIF2S1 protein toosendanin affects the expression of EIF2S1 mRNA
CTD
PMID:36801351
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eno1
enolase 1
increases activity affects binding
EXP
toosendanin results in increased activity of ENO1 protein toosendanin metabolite binds to ENO1 protein
CTD
PMID:30848893
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Fth1
ferritin heavy chain 1
decreases expression
ISO
toosendanin results in decreased expression of FTH1 mRNA; toosendanin results in decreased expression of FTH1 protein
CTD
PMID:36801351
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gpt
glutamic--pyruvic transaminase
increases expression
ISO
toosendanin results in increased expression of ALT protein
CTD
PMID:36801351
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
toosendanin results in decreased expression of GPX4 mRNA; toosendanin results in decreased expression of GPX4 protein
CTD
PMID:36801351
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases lipidation
ISO
toosendanin analog results in increased lipidation of MAP1LC3B protein; toosendanin results in increased lipidation of MAP1LC3B protein
CTD
PMID:34742683
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k1
mitogen activated protein kinase kinase 1
decreases expression
ISO
toosendanin results in decreased expression of MAP2K1 protein modified form
CTD
PMID:23111283
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mir194-1
microRNA 194-1
increases expression
ISO
toosendanin results in increased expression of MIR194-1 mRNA
CTD
PMID:28844483
NCBI chr13:96,851,166...96,851,248
Ensembl chr13:96,851,166...96,851,248
G
Ncoa4
nuclear receptor coactivator 4
affects expression increases expression
ISO
toosendanin affects the expression of NCOA4 mRNA toosendanin results in increased expression of NCOA4 protein
CTD
PMID:36801351
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression
ISO
toosendanin results in increased expression of PARP1 protein modified form
CTD
PMID:23111283
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Slc40a1
solute carrier family 40 member 1
decreases expression
ISO
toosendanin results in decreased expression of SLC40A1 mRNA; toosendanin results in decreased expression of SLC40A1 protein
CTD
PMID:36801351
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Sqstm1
sequestosome 1
decreases expression
ISO
toosendanin results in decreased expression of SQSTM1 protein
CTD
PMID:34742683
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation
ISO
toosendanin results in decreased phosphorylation of STAT3 protein
CTD
PMID:37946196
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tfrc
transferrin receptor
increases expression affects expression
ISO
toosendanin results in increased expression of TFRC protein toosendanin affects the expression of TFRC mRNA
CTD
PMID:36801351
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tpi1
triosephosphate isomerase 1
decreases activity affects binding
EXP
toosendanin results in decreased activity of TPI1 protein toosendanin metabolite binds to TPI1 protein
CTD
PMID:30848893
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19831
chemical entity
19829
atom
19829
nonmetal atom
19767
carbon atom
19724
organic molecular entity
19724
isoprenoid
14029
terpenoid
13728
triterpenoid
871
limonoid
149
(6R,6As,6bR,7aS,10R,10aS,12bR)-10-(furan-3-yl)-4,4,6a,10a,12b-pentamethyl-3,8-dioxo-3,4,4a,5,6,6a,7a,8,10,10a,11,12,12a,12b-tetradecahydronaphtho[2,1-f]oxireno[d]isochromen-6-yl acetate
0
1,2-diacetyltrichagmalin C
0
1,3-diacetylvilasinin
0
1,30-diacetyltrichagmalin F
0
12-O-deacetyltrichilin H
0
12alpha-Hydroxyamoorstatin
0
14-deoxyxyloccensin K
0
15-acetyltrichagmalin C
0
15-acetyltrichagmalin E
0
15-hydroxyazadiradione
0
17-defurano-17-oxosalannin
0
17-epi-17-hydroxyazadiradione
0
17-epiazadiradione +
0
17-hydroxyazadiradione
0
2',3'-dihydrosalannin
0
2-acetyloxy-3-methylpentanoic acid [(3S,3aR,4R,5R)-6-[(2S,4R,5S)-5-acetyloxy-2-(acetyloxymethyl)-3-(2-methoxy-2-oxoethyl)-2,4-dimethyl-7-oxo-4-oxepanyl]-5-formyloxy-3-(3-furanyl)-7a-hydroxy-3a-methyl-7-methylene-1-oxo-3,4,5,6-tetrahydro-2H-inden-4-yl] ester
0
20,21,22,23-tetrahydro-23-oxoazadirone
0
23-epivepaol
0
28-deoxonimbolide
3
3-acetyl-11-methoxy-1-tigloylazadirachtinin
0
3-acetyl-7-tigloylvilasinin lactone
0
3-deacetylsalannin
0
30-acetyltrichagmalin F
0
6-acetylnimbandiol
0
6-deacetylnimbin
0
7-acetyl-16,17-dehydro-16-hydroxyneotrichilenone
0
7-benzoylnimbocinol
0
7-deacetyl-17-epinimolicinol
0
7-deacetyl-7-benzoylepoxyazadiradione
0
7-deacetyl-7-benzoylgedunin
0
7-deacetylgedunin
0
7alpha-Obacunyl acetate
0
CEDRELONE
8
Chisomicine B
0
DIHYDROGEDUNIN
0
Deacetylnomilin
0
FISSINOLIDE
0
HAVANENSIN TRIACETATE
0
HEUDELOTTIN C
0
Harrisonin
0
Humilin B
0
KHAYASIN
0
Khivorin
0
Khivorine
0
LSM-4386
0
Limonexic acid
0
Limonoate A-ring-lactone
0
Methyl 2-[13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]-2-hydroxyacetate
0
Methyl 2-[6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.111,14.02,11.05,10]octadec-9-en-16-yl]acetate
0
Methyl 6-hydroxyangolensate
0
Obacunone
14
Protoxylocarpin A
0
Protoxylocarpin B
0
Protoxylocarpin C
0
Protoxylocarpin D
0
Protoxylocarpin E
0
Trichilin A
0
XYLOCARPUS A
0
Zapoterin
0
[(1R,2S,4R,6R,9R,10S,11R,12S,14R,15R,18R)-14-Acetyloxy-6-(furan-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadec-7-en-12-yl] (E)-2-methylbut-2-enoate
0
[(1S,6S,7R,10R,15S,16R,18S,19R,20R)-6-(3-Furyl)-8,9,18,19,20-pentahydroxy-3-(1-hydroxy-2-methylpropylidene)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.114,17.01,10.02,7.010,15.014,19]docos-16-yl]acetic acid
0
[12-acetyloxy-6-(furan-3-yl)-14-hydroxy-1,7,11,15,15-pentamethyl-5-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-18-yl] acetate
0
[13-Acetyloxy-7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-15-yl] acetate
0
[14-acetyloxy-6-(furan-3-yl)-12-hydroxy-1,7,11,15,15-pentamethyl-5-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-18-yl] acetate
0
[3-acetyloxy-16-(furan-3-yl)-2,7,7,11,17-pentamethyl-18-(2-methylpropanoyloxy)-5-oxo-6,13-dioxapentacyclo[9.8.0.02,8.012,14.012,17]nonadecan-10-yl] (E)-2-methylbut-2-enoate
0
[6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.01,10.02,4.02,7.011,18.015,23]tricosan-14-yl] 2-methylbutanoate
0
alpha-nimolactone
0
azadirachtin +
31
azadiradione +
4
azadiradionolide
0
azadirone +
0
beta-nimolactone
0
delta(8,14)-2-hydroxy-6-deoxyswietenine
0
deoxylimonoic acid
0
deoxylimonoic acid D-ring-lactone
0
desfuranoazadiradione
0
epoxyazadiradione +
0
gedunin +
83
limonin +
21
limonoic acid
0
nimbin +
0
nimbocinol +
0
nimolicinol
0
nomilin
1
ohchinin acetate
0
proceranolide
0
ruageanin B
0
salannin +
0
skimmiarepin A
0
skimmiarepin C
0
toosendanin
26
trichagmalin A
0
trichagmalin B
0
trichagmalin C +
0
trichagmalin D
0
trichagmalin E +
0
trichagmalin F +
0
trichanolide
0
vepaol
0
xylocarpin J
0
Path 2
CHEBI ontology
19831
subatomic particle
19829
composite particle
19829
hadron
19829
baryon
19829
nucleon
19829
atomic nucleus
19829
atom
19829
main group element atom
19779
main group molecular entity
19779
s-block molecular entity
19617
hydrogen molecular entity
19604
hydrides
19102
organic hydride
18674
organic fundamental parent
18674
hydrocarbon
18410
terpene
14029
triterpene
875
triterpenoid
871
limonoid
149
(6R,6As,6bR,7aS,10R,10aS,12bR)-10-(furan-3-yl)-4,4,6a,10a,12b-pentamethyl-3,8-dioxo-3,4,4a,5,6,6a,7a,8,10,10a,11,12,12a,12b-tetradecahydronaphtho[2,1-f]oxireno[d]isochromen-6-yl acetate
0
1,2-diacetyltrichagmalin C
0
1,3-diacetylvilasinin
0
1,30-diacetyltrichagmalin F
0
12-O-deacetyltrichilin H
0
12alpha-Hydroxyamoorstatin
0
14-deoxyxyloccensin K
0
15-acetyltrichagmalin C
0
15-acetyltrichagmalin E
0
15-hydroxyazadiradione
0
17-defurano-17-oxosalannin
0
17-epi-17-hydroxyazadiradione
0
17-epiazadiradione +
0
17-hydroxyazadiradione
0
2',3'-dihydrosalannin
0
2-acetyloxy-3-methylpentanoic acid [(3S,3aR,4R,5R)-6-[(2S,4R,5S)-5-acetyloxy-2-(acetyloxymethyl)-3-(2-methoxy-2-oxoethyl)-2,4-dimethyl-7-oxo-4-oxepanyl]-5-formyloxy-3-(3-furanyl)-7a-hydroxy-3a-methyl-7-methylene-1-oxo-3,4,5,6-tetrahydro-2H-inden-4-yl] ester
0
20,21,22,23-tetrahydro-23-oxoazadirone
0
23-epivepaol
0
28-deoxonimbolide
3
3-acetyl-11-methoxy-1-tigloylazadirachtinin
0
3-acetyl-7-tigloylvilasinin lactone
0
3-deacetylsalannin
0
30-acetyltrichagmalin F
0
6-acetylnimbandiol
0
6-deacetylnimbin
0
7-acetyl-16,17-dehydro-16-hydroxyneotrichilenone
0
7-benzoylnimbocinol
0
7-deacetyl-17-epinimolicinol
0
7-deacetyl-7-benzoylepoxyazadiradione
0
7-deacetyl-7-benzoylgedunin
0
7-deacetylgedunin
0
7alpha-Obacunyl acetate
0
CEDRELONE
8
Chisomicine B
0
DIHYDROGEDUNIN
0
Deacetylnomilin
0
FISSINOLIDE
0
HAVANENSIN TRIACETATE
0
HEUDELOTTIN C
0
Harrisonin
0
Humilin B
0
KHAYASIN
0
Khivorin
0
Khivorine
0
LSM-4386
0
Limonexic acid
0
Limonoate A-ring-lactone
0
Methyl 2-[13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]-2-hydroxyacetate
0
Methyl 2-[6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.111,14.02,11.05,10]octadec-9-en-16-yl]acetate
0
Methyl 6-hydroxyangolensate
0
Obacunone
14
Protoxylocarpin A
0
Protoxylocarpin B
0
Protoxylocarpin C
0
Protoxylocarpin D
0
Protoxylocarpin E
0
Trichilin A
0
XYLOCARPUS A
0
Zapoterin
0
[(1R,2S,4R,6R,9R,10S,11R,12S,14R,15R,18R)-14-Acetyloxy-6-(furan-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadec-7-en-12-yl] (E)-2-methylbut-2-enoate
0
[(1S,6S,7R,10R,15S,16R,18S,19R,20R)-6-(3-Furyl)-8,9,18,19,20-pentahydroxy-3-(1-hydroxy-2-methylpropylidene)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.114,17.01,10.02,7.010,15.014,19]docos-16-yl]acetic acid
0
[12-acetyloxy-6-(furan-3-yl)-14-hydroxy-1,7,11,15,15-pentamethyl-5-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-18-yl] acetate
0
[13-Acetyloxy-7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-15-yl] acetate
0
[14-acetyloxy-6-(furan-3-yl)-12-hydroxy-1,7,11,15,15-pentamethyl-5-oxo-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-18-yl] acetate
0
[3-acetyloxy-16-(furan-3-yl)-2,7,7,11,17-pentamethyl-18-(2-methylpropanoyloxy)-5-oxo-6,13-dioxapentacyclo[9.8.0.02,8.012,14.012,17]nonadecan-10-yl] (E)-2-methylbut-2-enoate
0
[6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.01,10.02,4.02,7.011,18.015,23]tricosan-14-yl] 2-methylbutanoate
0
alpha-nimolactone
0
azadirachtin +
31
azadiradione +
4
azadiradionolide
0
azadirone +
0
beta-nimolactone
0
delta(8,14)-2-hydroxy-6-deoxyswietenine
0
deoxylimonoic acid
0
deoxylimonoic acid D-ring-lactone
0
desfuranoazadiradione
0
epoxyazadiradione +
0
gedunin +
83
limonin +
21
limonoic acid
0
nimbin +
0
nimbocinol +
0
nimolicinol
0
nomilin
1
ohchinin acetate
0
proceranolide
0
ruageanin B
0
salannin +
0
skimmiarepin A
0
skimmiarepin C
0
toosendanin
26
trichagmalin A
0
trichagmalin B
0
trichagmalin C +
0
trichagmalin D
0
trichagmalin E +
0
trichagmalin F +
0
trichanolide
0
vepaol
0
xylocarpin J
0